Advertisement

Topics

Companies Related to "Ginkgo Bioworks Announces Chief Business Officer Head Metabolic" [Most Relevant Company Matches] RSS

01:05 EDT 21st October 2017 | BioPortfolio

Here are the most relevant search results for "Ginkgo Bioworks Announces Chief Business Officer Head Metabolic" found in our extensive corporate database of over 50,000 company records.

Showing "Ginkgo Bioworks Announces Chief Business Officer Head Metabolic" Companies 1–25 of 5,400+

Extremely Relevant

Ginkgo Bioworks

Ginkgo Bioworks is an organism design company that is building organisms to spec for customers across markets including nutrition, health and consumer goods. The company’s organism engineers work directly with customers including Fortune 500 companies to design microbes for their specific needs. The company was founded in 2008 by Tom Knight, a world-r...


Vantage Oncology, LLC

Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, LLC owns, operates and manages radiation oncology centers of excellence. The company’s founding principles were to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology curre...

Vantage Oncology

Founded in October 2002, Vantage Oncology acquires, joint ventures, develops and operates radiation oncology centers of excellence. The Company was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies. Recent developments at Vantage include the establishment of multi-specialty oncology care organizations ...


Relevant

Origo Acquisition Corporation

Origo Acquisition Corporation is a public investment vehicle formed for the purpose of effecting a merger, acquisition or similar business combination. Origo is led by Chief Executive Officer Edward J. Fred, Chief Financial Officer Jose M. Aldeanueva and Directors Stephen B. Pudles, Jeffrey J. Gutovich and Barry Rodgers. Origo’s securities are quoted ...

REVOLUTION Medicines

The REVOLUTION Medicines team brings deep expertise and a track record of building exceptional life sciences companies. In addition to Dr. Goldsmith, founding president and chief executive officer and Dr. Burke, founder and scientific advisory board chairman, the team includes: David Pompliano, Ph.D., founding chief scientific officer, who is a leading ...

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified by Ryuj...

Vmersion-Health

Vmersion-Health, developer of Gluco-Share, is a California Limited Partnership founded in 2011. Vmersion-Health develops and publishes social media applications for health-related causes, with a commitment to improved health through better communication and social support mechanisms. Joseph “Joe” Madden is president and Chief Executive Officer; J...

Sucampo Pharmaceuticals, Inc. and Numab AG

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids wa...

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymic (15-PGDH) transformation of certain fatty acids, was first identified ...

Berkeley BioWorks, Inc

Berkeley BioWorks is an engineering consultancy that specializes in the following key services.Whatever the scale of the project, Berkeley BioWorks turns ideas into robust solutions, on time and on budget.The company combines electro-mechanical engineering expertise with established partners in software development, thermal/fluid analysis and industrial design.

China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare products, ginkgo cosmetics, daily-use ...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on prostones. The therapeutic potential of prostones, which occur naturally in the human body as a result of enzymatic (15-PGDH) transformation of certain fatty acids, was first identified ...

MedDay

MedDay is a privately held biotechnology company developing new drugs for nervous system disorders. The company was founded in 2011 by Frédéric Sedel, MD, PhD (Chief Executive Officer), a leading neurologist and neuroscientist; and Guillaume Brion, MD (Chief Operating Officer) who has 25 years of experience in drug development and clinical research i...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. Harbinger Capital Partners is led by Phil Falcone who has been the Chief Executive Officer and Chief Investment Officer of funds affiliated with or managed by Harbinger Capital Partners ...

IntraBiotics Pharmaceuticals Inc.

On June 20, 2005, IntraBiotics Pharmaceuticals, Inc. announced that the Company was terminating all regular employees and ceasing all operations. It was also announced that the Company was appointing Hickey & Hill, Inc. to assume responsibilities for the day-to-day administration of the Company and that Mr. Hickey was to be designated Chief Executive Officer. Mr. Hickey has since been appointed Ch...

Greater Medical Center Group

The Greater Medical Center Group (GMCG) is a provider of U.S. Clerkships for International Medical Students and Graduates. As a network of professionals and educators, GMCG's mission is to standardize the clinical experience of medical students educated abroad while providing support services to international medical schools. Key executives are Dr. Stephen M. Cohen, Chief Executive Officer; ...

Memphis Bioworks Foundation

The Memphis Bioworks Foundation, a not-for-profit organization, was formed to lead the collaboration among public, private, academic, and government entities to accelerate the growth of the bioscience industry in the region. Memphis Bioworks strives to leverage and expand the regional strengths in the biosciences through education, research, job training, ...

China YCT International Group Inc.

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under the laws of the People's Republic of China, is a high-tech enterprise, which applies modern biological technology and integrates research & development, production and sales of ginkgo healthcare prod...

Interface Biologics

Toronto, Canada – August 26, 2005 - Interface Biologics Inc. announced today the appointment of Richard W. Sullivan to the position of President and Chief Executive Officer of the Company.Mr. Sullivan brings more than 30 years of senior management and executive experience in the life sciences industry, having held key positions in early stage corporations since 1990. Most recently, as Chief Exec...

AmeriLithium Corp.

Matthew Worrall, Chief Executive Officer

Palo Alto Investors, LLC

By: /s/ Will EdwardsName: Will Edwards, Chairman and Chief Investment Officer

Medivizor

Medivizor offers a patent-pending, personalized health information platform for individuals with serious or chronic illnesses. Users of Medivizor are benefiting from custom content, cutting-edge research, clear and authoritative descriptions of treatment options, individual-matched clinical trials, social engagement, and much more. Professor Steven ...

G & W Laboratories,Inc.

Carl Greenblatt founded G & W Laboratories, Inc. over eighty years ago upon his return from military service as a pharmacist with US forces in World War I. While establishing a reputation as an innovative specialist in suppository dosage forms, Carl guided G & W Laboratories with an uncompromising commitment to product integrity and customer service. In 1945, Carl's son, Burton, also a registered ...

CliniGenetics

CliniGenetics SA was created in 2000 by a group of cardiovascular research scientists. Mr Jean Louis Falco, an expert in financial activities and management is operating as chairman of the board of Director and CEO. Professor Gerard Marguerie whose operating as Chief Scientific Officer was substitute Director of Life Sciences at the Atomic Energy Agency and head of the functionnal genomics unit at...

The Vaccine and Gene Therapy Institute of Florida (VGTI Florida)

“We dedicate ourselves every single day to finding novel treatments for chronic diseases like cancer and HIV/AIDS,” said Mel Rothberg, Chief Operating Officer, VGTI Florida. “We’re pleased to have Catherine onboard. By leading our business development efforts, she will facilitate the commercial translation of therapeutic discoveries so that ...


More From BioPortfolio on "Ginkgo Bioworks Announces Chief Business Officer Head Metabolic"

Quick Search
Advertisement
 

Corporate Database Quicklinks